{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:25:46Z","timestamp":1762899946904,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10815-020-01847-x","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T03:47:48Z","timestamp":1591415268000},"page":"1583-1588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Why is use of donor eggs not viewed as treatment failure? A call for improvements in treatments with autologous oocytes"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-4167","authenticated-orcid":false,"given":"Norbert","family":"Gleicher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Barad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli Y.","family":"Adashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,6]]},"reference":[{"issue":"2","key":"1847_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/hsw\/hlw005","volume":"41","author":"LB Gezinski","year":"2016","unstructured":"Gezinski LB, Karandikar S, Carter J, White M. Exploring motivations, awareness of side effects, and attitudes among potential egg donors. Health Soc Work. 2016;41(2):75\u201383.","journal-title":"Health Soc Work"},{"issue":"2","key":"1847_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.fertnstert.2016.03.031","volume":"106","author":"H Letur","year":"2016","unstructured":"Letur H, Peigne M, Ohl J, Cedrin-Dunerin I, Mathieu-D\u2019Argent E, Scheffler F, et al. Hypertensive pathologies and egg donation pregnancies: results of a large comparative cohort study. Fertil Steril. 2016;106(2):284\u201390.","journal-title":"Fertil Steril"},{"issue":"4","key":"1847_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/humupd\/dmw006","volume":"22","author":"T Bracewell-Milnes","year":"2016","unstructured":"Bracewell-Milnes T, Saso S, Bora S, Ismail AM, Al-Memar M, Hamed AH, et al. Investigating psychological attitudes, motivations and experiences of oocyte donors, recipients and egg shares: a systematic review. Hum Reprod Update. 2016;22(4):450\u201365.","journal-title":"Hum Reprod Update"},{"key":"1847_CR4","unstructured":"CDC 2016, 2016 Assisted Reproductive Technology National Summary Report. https:\/\/www.cdc.gov\/art\/reports\/2016\/national-summary-figures.html"},{"key":"1847_CR5","unstructured":"SART 2016, https:\/\/www.sartcorsonline.com\/rptCSR_PublicMultYear.aspx?reportingYear=2016 (accessed March 4, 2019)."},{"key":"1847_CR6","unstructured":"Ethics Committee of the American Society for Reproductive Medicine 2012: Fertility treatment when the prognosis is very poor or futile: an ethics committee opinion. Fertil Steril 2019, 11(4):659\u2013663."},{"issue":"4","key":"1847_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.rbmo.2009.04.002","volume":"9","author":"A Hourvitz","year":"2009","unstructured":"Hourvitz A, Machtinger R, Maman E, Baum M, Dor J, Levron J. Assisted reproduction in women over 40 years of age: how old is too old? Reprod BioMed Online. 2009;9(4):599\u2013603.","journal-title":"Reprod BioMed Online"},{"issue":"1","key":"1847_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/bioe.12309","volume":"31","author":"F Baylis","year":"2017","unstructured":"Baylis F. Human nuclear genome transfer (so-called mitochondrial replacement): clearing the underbrush. Bioethics. 2017;31(1):7\u201319.","journal-title":"Bioethics"},{"key":"1847_CR9","doi-asserted-by":"crossref","unstructured":"Nuffield Council on Bioethics, Genome editing and human reproduction; 2018; http:\/\/nuffieldbioethics.org\/project\/genome-editing","DOI":"10.1515\/jwiet-2019-0012"},{"key":"1847_CR10","unstructured":"Kandel ER. The Age of Insight, Random House. New York; 2012. p. 47."},{"key":"1847_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1477-7827-12-63","volume":"12","author":"N Gleicher","year":"2014","unstructured":"Gleicher N, Kushnir VA, Weghofer A, Barad DH. The \u201cgraying\u201d of infertility services: an impending revolution nobody is ready for. Reprod Biol Endocrinol. 2014;12:63.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"1847_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.rbmo.2018.05.010","volume":"37","author":"N Gleicher","year":"2018","unstructured":"Gleicher N, Kushnir VA, Darmon S, Albertini DF, Barad DH. Older women using their own eggs? Issue framed with two oldest reported IVF pregnancies and a live birth. Reprod BioMed Online. 2018;37(2):172\u20137.","journal-title":"Reprod BioMed Online"},{"key":"1847_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1477-7827-9-23","volume":"9","author":"N Gleicher","year":"2011","unstructured":"Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol. 2011;9:23.","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"1847_CR14","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/humrep\/det033","volume":"28","author":"N Gleicher","year":"2013","unstructured":"Gleicher N, Kim A, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, et al. Hypoandrogenism is associated with diminished functional ovarian reserve. Hum Reprod. 2013;28(4):1084\u201391.","journal-title":"Hum Reprod"},{"issue":"3","key":"1847_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1530\/JOE-15-0246","volume":"226","author":"YG Wu","year":"2015","unstructured":"Wu YG, Barad DH, Kushnir VA, Lazzaroni E, Wang Q, Albertini DF, et al. Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval. J Endocrinol. 2015;226(3):167\u201380.","journal-title":"J Endocrinol"},{"issue":"1","key":"1847_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13048-018-0398-8","volume":"11","author":"YG Wu","year":"2018","unstructured":"Wu YG, Barad DH, Kushnir VA, Wang Q, Zhang L, Darmon SK, et al. With low ovarian reserve, Highly Individualized Egg Retrieval (HIER) improves IVF results by avoiding premature luteinization. J Ovarian Res. 2018;11(1):23.","journal-title":"J Ovarian Res"},{"key":"1847_CR17","unstructured":"Human Fertilization & Embryology Authority. https:\/\/www.hfea.gov.uk\/i-am\/women-over-38\/ (accessed March 4, 2019)."},{"key":"1847_CR18","unstructured":"Campbell D IVF treatment extended to women up to age 42 on NHS. Guardian 2012 http:\/\/www.the\nguardian.com\/society\/2012\/may\/22\/ivf-nhs-age-42-fertility (accessed March 4, 2019."},{"key":"1847_CR19","unstructured":"The Swedish National Council on Medical Ethics Summary of the original report \u201cAssisterad befruktning \u2013 etiska aspekter 2013:1\u201dpublished in Feb 2013. http:\/\/www.smer.se\/wp-content\/uploads\/2013\/03\/Slutversion-sammanfattning-eng- Assisted-reproduction.pdf."},{"key":"1847_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1472-6963-7-210","volume":"7","author":"R Klemetti","year":"2007","unstructured":"Klemetti R, Gissler M, Sev\u00f3n T, Hemminiki E. Resources allocation of in vitro fertilization: a nationwide register-based cohort study. BMC Health Service Res. 2007;7:210.","journal-title":"BMC Health Service Res"},{"key":"1847_CR21","unstructured":"Hamilton BE, Martin JA, Osterman MJK, Rossen LM Births: Provisional Data for 2018. NVSS vital statistics rapid release; Report No007, May 2019."},{"issue":"1","key":"1847_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12967-016-0924-7","volume":"14","author":"N Gleicher","year":"2016","unstructured":"Gleicher N, Kushnir VA, Sen A, Darmon SK, Weghofer A, Wu YG, et al. Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH. J Transl Med. 2016;14(1):172.","journal-title":"J Transl Med"},{"issue":"3","key":"1847_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10815-017-1088-y","volume":"35","author":"V Gunnala","year":"2018","unstructured":"Gunnala V, Irani M, Melnick A, Rosenwaks Z, Spandorfer S. One thousand seventy-eight autologous IVF cycles in women 45 years and older: the largest single-center cohort to date. J Assist Reprod Genet. 2018;35(3):435\u201340.","journal-title":"J Assist Reprod Genet"},{"key":"1847_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1477-7827-9-67","volume":"9","author":"N Gleicher","year":"2011","unstructured":"Gleicher N, Barad DH. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve. Reprod Biol Endocrinol. 2011;9:67.","journal-title":"Reprod Biol Endocrinol"},{"key":"1847_CR25","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3389\/fendo.2019.00650","volume":"19","author":"JL Yovich","year":"2019","unstructured":"Yovich JL, Regan SLP, Zaidi S, Keane KN. The concept of growth hormone deficiency affecting clinical prognosis in IVF. Front Endocrinol (Lausanne). 2019;19:650.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"1847_CR26","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1080\/09513590.2019.1594762","volume":"35","author":"S Wang","year":"2019","unstructured":"Wang S, Chen L, Fang J, Jiang W, Zhang N. Comparison of the pregnancy and obstetric outcomes between single cleavage-stage embryo transfer and single blastocyst transfer by time-lapse selection of embryos. Gynecol Endocrinol. 2019;35(9):792\u20135.","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"1847_CR27","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.rbmo.2019.08.003","volume":"39","author":"JS Xiao","year":"2019","unstructured":"Xiao JS, Healey M, Talmor A, Vollenhove B. When only one embryo is available, is it better to transfer on day-3 or to grow on? Reprod BioMed Online. 2019;39(6):916\u201323.","journal-title":"Reprod BioMed Online"},{"issue":"6","key":"1847_CR28","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.fertnstert.2019.07.1346","volume":"112","author":"S Munn\u00e9","year":"2019","unstructured":"Munn\u00e9 S, Kaplan B, Frattarelli JL, Child T, Nakhuda G, Sharma FN, et al. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single-frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertil Steril. 2019;112(6):1071\u20139 e7.","journal-title":"Fertil Steril"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-020-01847-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-020-01847-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-020-01847-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T23:40:08Z","timestamp":1622936408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-020-01847-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,6]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1847"],"URL":"https:\/\/doi.org\/10.1007\/s10815-020-01847-x","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"type":"print","value":"1058-0468"},{"type":"electronic","value":"1573-7330"}],"subject":[],"published":{"date-parts":[[2020,6,6]]},"assertion":[{"value":"21 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"N.G. is the owner of a for-profit fertility centre, <i>the CHR<\/i> in New York, NY. He and D.H.B. are co-inventors on several pending and already awarded US patents claiming therapeutic benefits from androgen supplementation in women with low functional ovarian reserve. Both are also co-inventors on patents relating to the <i>FMR1<\/i> gene in diagnostic functions in female fertility and to AMH as a potentially therapeutic agent in female infertility. N.G. and D.H.B. receive royalties from Fertility Nutraceuticals, LLC, in which N.G. also holds shares. Both in the past received research grants, travel funds and\/or speaker honoraria from pharma and\/or medical device companies, though none in any way related to hear presented materials. E.Y.A. has no conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}